Dergi makalesi Açık Erişim
Celik-Tekeli, Merve; Celebi, Nevin; Tekeli, M. Yasin; Aktas, Yesim
{ "conceptrecid": "233605", "created": "2022-10-07T08:48:10.804384+00:00", "doi": "10.1016/j.ejps.2020.105644", "files": [ { "bucket": "36c90be4-a5a5-40fc-bd02-96e9f94c6c19", "checksum": "md5:a703667f4c5639e225e7c625f70fc368", "key": "bib-8cded7d2-487e-4bdd-96f1-84e7bfd2b50a.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/36c90be4-a5a5-40fc-bd02-96e9f94c6c19/bib-8cded7d2-487e-4bdd-96f1-84e7bfd2b50a.txt" }, "size": 215, "type": "txt" } ], "id": 233606, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1016/j.ejps.2020.105644.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/36c90be4-a5a5-40fc-bd02-96e9f94c6c19", "doi": "https://doi.org/10.1016/j.ejps.2020.105644", "html": "https://aperta.ulakbim.gov.tr/record/233606", "latest": "https://aperta.ulakbim.gov.tr/api/records/233606", "latest_html": "https://aperta.ulakbim.gov.tr/record/233606" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "name": "Celik-Tekeli, Merve" }, { "name": "Celebi, Nevin" }, { "affiliation": "Erciyes Univ, Fac Vet Med, Dept Pharmacol & Toxicol, TR-38238 Kayseri, Turkey", "name": "Tekeli, M. Yasin" }, { "affiliation": "Erciyes Univ, Fac Pharm, Dept Pharmaceut Technol, TR-38238 Kayseri, Turkey", "name": "Aktas, Yesim" } ], "description": "The objective of this study is to develop a new self-nanoemulsifying system containing exendin-4 with or without enzyme inhibitor chymostatin and to evaluate the effects of oral administration of exendin-4 and exendin-4/chymostatin loaded self nanoemulsifying system on plasma exendin-4, plasma insulin, blood glucose levels and to compare with the oral and subcutaneous administration of exendin-4 in non-diabetic and streptozotocin-induced type 2 diabetic rats. Exendin-4 and exendin-4/chymostatin loaded self-nanoemulsifying system containing ethyl oleate as the oil phase, Cremophor EL (R)/Labrasol (R) as the surfactants and propylene glycol as the co-solvent were prepared. The mean droplet size, polydispersity index, zeta potential and viscosity of exendin-4 loaded self-nanoemulsifying system were found as 24.28 +/- 0.43 nm, 0.17 +/- 0.01, -1.28 +/- 3.61 mV, 79.60 +/- 3.30 m.Pas, respectively. The mean droplet size, polydispersity index, zeta potential and viscosity of exendin-4/chymostatin loaded self-nanoemulsifying system were found as 20.25 +/- 0.35 nm, 0.11 +/- 0.02, -1.85 +/- 2.49 mV, 100.02 +/- 7.65 m.Pas, respectively according to our previous study. In the present study, we focused on long-term physical stability studies, pharmacokinetic studies and pharmacodynamic studies of prepared self-nanoemulsifying systems. According to the long-term physical stability data, exendin-4 and exendin-4/chymostatin loaded self-nanoemulsifying systems were found stable both at 5 degrees C +/- 3 degrees C and at 25 degrees C +/- 60% RH for 12 months. Exendin-4 and exendin-4/chymostatin loaded self-nanoemulsifying systems increased AUC and C-max values in non-diabetic rats compared to the oral exendin-4 solution. In diabetic rats, exendin-4/chymostatin loaded self nanoemulsifying systems increased C-max values compared to the exendin-4 solution. Exendin-4/chymostatin loaded self-nanoemulsifying system decreased inter-subject variability compared to commercial Byetta (R). At 30th minute after administration of exendin-4 loaded self-nanoemulsifying system, exendin-4/chymostatin loaded self nanoemulsifying system and Byetta (R), blood glucose levels decreased to 23%, 25%, 29%, respectively. It has been shown that pharmacodynamic response is close to Byetta (R) with exendin-4/chymostatin self-nanoemulsifying system oral administration. In conclusion, a self nanoemulsifying system was found to be a suitable carrier system, and the combination with enzyme inhibitor chymostatin is thought to be promising for oral delivery of exendin-4.", "doi": "10.1016/j.ejps.2020.105644", "has_grant": false, "journal": { "title": "EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES", "volume": "158" }, "license": { "id": "cc-by" }, "publication_date": "2021-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "233606" }, "parent": { "pid_type": "recid", "pid_value": "233605" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "science_branches": [ "Di\u011fer" ], "title": "Evaluation of the hypoglycemic effect of exendin-4's new oral self-nanoemulsifying system in rats" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 6.0, "unique_downloads": 6.0, "unique_views": 17.0, "version_downloads": 6.0, "version_unique_downloads": 6.0, "version_unique_views": 17.0, "version_views": 18.0, "version_volume": 1290.0, "views": 18.0, "volume": 1290.0 }, "updated": "2022-10-07T08:48:10.858263+00:00" }
Görüntülenme | 18 |
İndirme | 6 |
Veri hacmi | 1.3 kB |
Tekil görüntülenme | 17 |
Tekil indirme | 6 |